1358 Stock Overview
An investment holding company, operates as a medical device company in China, India, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
PW Medtech Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.99 |
| 52 Week High | HK$1.22 |
| 52 Week Low | HK$0.65 |
| Beta | 0.75 |
| 1 Month Change | -3.88% |
| 3 Month Change | -13.16% |
| 1 Year Change | 25.32% |
| 3 Year Change | -4.81% |
| 5 Year Change | -32.19% |
| Change since IPO | -71.79% |
Recent News & Updates
Recent updates
PW Medtech Group's (HKG:1358) Solid Earnings Are Supported By Other Strong Factors
Sep 26
Here's Why PW Medtech Group Limited's (HKG:1358) CEO Might See A Pay Rise Soon
Jun 07There's Reason For Concern Over PW Medtech Group Limited's (HKG:1358) Price
Mar 14We Think PW Medtech Group (HKG:1358) Can Manage Its Debt With Ease
Nov 23How Much Have PW Medtech Group (HKG:1358) Shareholders Earned On Their Investment Over The Last Five Years?
Feb 18Should You Rely On PW Medtech Group's (HKG:1358) Earnings Growth?
Jan 23
Here's Why PW Medtech Group (HKG:1358) Can Manage Its Debt Responsibly
Dec 28Should You Be Adding PW Medtech Group (HKG:1358) To Your Watchlist Today?
Dec 10What You Need To Know About PW Medtech Group Limited's (HKG:1358) Investor Composition
Nov 22Shareholder Returns
| 1358 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | -2.0% | -3.8% | -2.2% |
| 1Y | 25.3% | -28.7% | 18.3% |
Return vs Industry: 1358 exceeded the Hong Kong Medical Equipment industry which returned -28.7% over the past year.
Return vs Market: 1358 exceeded the Hong Kong Market which returned 18.3% over the past year.
Price Volatility
| 1358 volatility | |
|---|---|
| 1358 Average Weekly Movement | 3.2% |
| Medical Equipment Industry Average Movement | 9.1% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 18.7% |
| 10% least volatile stocks in HK Market | 4.1% |
Stable Share Price: 1358 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 1358's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 1,302 | Yue'e Zhang | www.pwmedtech.com |
PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, North America, and internationally. It operates through three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical devices; high flux hemodialyzers, low flux hemodialyzers, hemodiafilters, and hemoperfutors; and animal-derived regenerative medical biomaterials and human tissue repair alternative products.
PW Medtech Group Limited Fundamentals Summary
| 1358 fundamental statistics | |
|---|---|
| Market cap | HK$1.47b |
| Earnings (TTM) | HK$162.31m |
| Revenue (TTM) | HK$739.52m |
9.1x
P/E Ratio2.0x
P/S RatioIs 1358 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1358 income statement (TTM) | |
|---|---|
| Revenue | CN¥694.49m |
| Cost of Revenue | CN¥302.77m |
| Gross Profit | CN¥391.72m |
| Other Expenses | CN¥239.29m |
| Earnings | CN¥152.43m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.10 |
| Gross Margin | 56.40% |
| Net Profit Margin | 21.95% |
| Debt/Equity Ratio | 0.06% |
How did 1358 perform over the long term?
See historical performance and comparisonDividends
9.2%
Current Dividend Yield88%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 18:20 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PW Medtech Group Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jessica Li | BofA Global Research |
| Kevin Leung | Haitong International Research Limited (Inactive) |
| Bin Li | Morgan Stanley |